jCell (Famzeretcel)

Famzeretcel · jCyte, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for jCell (Famzeretcel), covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) [Phase 2]